Top

Published in:

01-06-2021 | Transurethral Prostate Resection | Original Article

Bladder infusion versus standard catheter removal for trial of void: a systematic review and meta-analysis

Authors: Joshua Makary, Kevin Phan, George McClintock, Marinelle Doctor, David Habashy, Sean Heywood, Steve P. McCombie, Mohan Arianayagam, Bertram Canagasingham, Richard Ferguson, Ahmed Goolam, Mohamed Khadra, Raymond Ko, Celi Varol, Matthew Winter, Matthew J. Roberts

Published in: World Journal of Urology | Issue 6/2021

Abstract

Purpose

To compare the efficacy and time-to-discharge of two methods of trial of void (TOV): bladder infusion versus standard catheter removal.

Methods

Electronic searches for randomized controlled trials (RCTs) comparing bladder infusion versus standard catheter removal were performed using multiple electronic databases from dates of inception to June 2020. Participants underwent TOV after acute urinary retention or postoperatively after intraoperative indwelling catheter (IDC) placement. Quality assessment and meta-analyses were performed, with odds ratio and mean time difference used as the outcome measures.

Results

Eight studies, comprising 977 patients, were included in the final analysis. Pooled meta-analysis demonstrated that successful TOV was significantly higher in the bladder infusion group compared to standard TOV (OR 2.41, 95% CI 1.53–3.8, p = 0.0005), without significant heterogeneity (I²=19%). The bladder infusion group had a significantly shorter time-to-decision in comparison to standard TOV (weighted mean difference (WMD)—148.96 min, 95% CI − 242.29, − 55.63, p = 0.002) and shorter time-to-discharge (WMD − 89.68 min, 95% CI − 160.55, − 18.88, p = 0.01). There was no significant difference in complication rates between the two groups.

Conclusion

The bladder infusion technique of TOV may be associated with a significantly increased likelihood of successful TOV and reduced time to discharge compared to standard TOV practices.

Available only for authorised users

Baldini G, Bagry H, Aprikian A, Carli F (2009) Postoperative urinary retention: anesthetic and perioperative considerations. Anesthesiology 110(5):1139–1157. https://doi.org/10.1097/aln.0b013e31819f7aeaCrossRefPubMed

Mowat A, Brown B, Pelecanos A, Mowat V, Frazer M (2018) Infusion-fill method versus standard auto-fill trial of void protocol following a TVT-exact procedure: a randomised controlled trial. Austr N Zeal J Obstet Gynaecol 58(5):564–569. https://doi.org/10.1111/ajo.12780CrossRef

Keita H, Diouf E, Tubach F, Brouwer T, Dahmani S, Mantz J, Desmonts J-M (2005) Predictive factors of early postoperative urinary retention in the postanesthesia care unit. Anesth Analg 101(2):592–596. https://doi.org/10.1213/01.ane.0000159165.90094.40CrossRefPubMed

Mueller EJ, Zeidman EJ, Desmond PM, Thompson IM, Optenberg SA, Wasson J (1996) Reduction of length of stay and cost of transurethral resection of the prostate by early catheter removal. Br J Urol 78(6):893–896. https://doi.org/10.1046/j.1464-410X.1996.01614.xCrossRefPubMed

Noble JG, Menzies D, Cox PJ, Edwards L (1990) Midnight removal: an improved approach to removal of catheters. Br J Urol 65(6):615–617. https://doi.org/10.1111/j.1464-410X.1990.tb14830.xCrossRefPubMed

Odom BD, Ehlert M, Gupta P, Cholyway R, Boura JA, Killinger KA, Sirls LT (2016) Clinical comparison of 2 trial-of-void methods after outpatient midurethral sling placement. Female Pelvic Med Reconstruct Surg 22(3):172–174. https://doi.org/10.1097/spv.0000000000000258CrossRef

Lyth DR, Braslis K, Iacovou JW (1997) The infusion trial of micturition. Br J Urol 79(1):94–95. https://doi.org/10.1046/j.1464-410x.1997.30520.xCrossRefPubMed

Boccola MA, Sharma A, Taylor C, Wong LM, Travis D, Chan S (2011) The infusion method trial of void vs standard catheter removal in the outpatient setting: a prospective randomized trial. BJU Int 107(Suppl 3):43–46. https://doi.org/10.1111/j.1464-410X.2011.10044.xCrossRefPubMed

Chao L, Mansuria S (2019) Postoperative bladder filling after outpatient laparoscopic hysterectomy and time to discharge: a randomized controlled trial. Obstet Gynecol 133(5):879–887. https://doi.org/10.1097/aog.0000000000003191CrossRefPubMedPubMedCentral

10.

Du J, Marshall D, Leyland J, Shaw L, Broome KE, Mason DFC (2013) Prospective, multicentre, randomized controlled trial of bladder filling prior to trial of void on the timing of discharge. ANZ J Surg 83(4):239–242. https://doi.org/10.1111/j.1445-2197.2012.06253.xCrossRefPubMed

11.

Foster RT Sr, Borawski KM, South MM, Weidner AC, Webster GD, Amundsen CL (2007) A randomized, controlled trial evaluating 2 techniques of postoperative bladder testing after transvaginal surgery. Am J Obstet Gynecol 197(6):627.e621–627.e624. https://doi.org/10.1016/j.ajog.2007.08.017CrossRef

12.

Moher D, Liberati A, Tetzlaff J, Altman DG, The PG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097CrossRefPubMedPubMedCentral

13.

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, Cates CJ, Cheng H-Y, Corbett MS, Eldridge SM, Emberson JR, Hernán MA, Hopewell S, Hróbjartsson A, Junqueira DR, Jüni P, Kirkham JJ, Lasserson T, Li T, McAleenan A, Reeves BC, Shepperd S, Shrier I, Stewart LA, Tilling K, White IR, Whiting PF, Higgins JPT (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. https://doi.org/10.1136/bmj.l4898CrossRefPubMed

14.

Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924–926. https://doi.org/10.1136/bmj.39489.470347.ADCrossRefPubMedPubMedCentral

15.

Wilson ID, Bramwell SP, Hollins GW (2000) A randomized trial comparing bladder infusion with standard catheter removal after transurethral resection of the prostate. BJU Int 86(9):993–995. https://doi.org/10.1046/j.1464-410x.2000.00963.xCrossRefPubMed

16.

Mills JT, Rapp DE, Shaw NM, Hougen HY, Agard HE, Case RM Jr, McMurry TL, Schenkman NS, Krupski TL (2019) Effect of active versus passive void trials on time to patient discharge, urinary tract infection, and urinary retention: a randomized clinical trial. World J Urol. https://doi.org/10.1007/s00345-019-03005-0CrossRefPubMed

17.

Cannoodt LJ, Knickman JR (1984) The effect of hospital characteristics and organizational factors on pre- and postoperative lengths of hospital stay. Health Serv Res 19(5):561–585PubMedPubMedCentral

18.

Buttigieg SC, Abela L, Pace A (2018) Variables affecting hospital length of stay: a scoping review. J Health Organiz Manag 32(3):463–493. https://doi.org/10.1108/jhom-10-2017-0275CrossRef

19.

Jakobsson L (2002) Indwelling catheter treatment and health-related quality of life in men with prostate cancer in comparison with men with benign prostatic hyperplasia. Scand J Caring Sci 16(3):264–271. https://doi.org/10.1046/j.1471-6712.2002.00096.xCrossRefPubMed

20.

Pugh JD, Twigg DE, Giles M, Myers H, Gelder L, Davis SM, King M (2015) Impact and costs of home-based trial of void compared with the day care setting. J Adv Nurs 71(3):559–569. https://doi.org/10.1111/jan.12525CrossRefPubMed

21.

Colli J, Tojuola B, Patterson AL, Ledbetter C, Wake RW (2014) National trends in hospitalization from indwelling urinary catheter complications, 2001-2010. Int Urol Nephrol 46(2):303–308. https://doi.org/10.1007/s11255-013-0524-xCrossRefPubMed

22.

Zowawi HM, Harris PN, Roberts MJ, Tambyah PA, Schembri MA, Pezzani MD, Williamson DA, Paterson DL (2015) The emerging threat of multidrug-resistant gram-negative bacteria in urology. Nat Rev Urol 12(10):570–584. https://doi.org/10.1038/nrurol.2015.199CrossRefPubMed

23.

Jiwrajka M, Yaxley W, Ranasinghe S, Perera M, Roberts MJ, Yaxley J (2018) Drugs for benign prostatic hypertrophy. Aust Prescr 41(5):150–153. https://doi.org/10.18773/austprescr.2018.045CrossRefPubMedPubMedCentral

24.

Morton A, Williams M, Perera M, Teloken PE, Donato P, Ranasinghe S, Chung E, Bolton D, Yaxley J, Roberts MJ. Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population-based data. BJU Int. https://doi.org/10.1111/bju.15098 (in press)

Title: Bladder infusion versus standard catheter removal for trial of void: a systematic review and meta-analysis
Authors: Joshua Makary
Kevin Phan
George McClintock
Marinelle Doctor
David Habashy
Sean Heywood
Steve P. McCombie
Mohan Arianayagam
Bertram Canagasingham
Richard Ferguson
Ahmed Goolam
Mohamed Khadra
Raymond Ko
Celi Varol
Matthew Winter
Matthew J. Roberts
Publication date: 01-06-2021
Publisher: Springer Berlin Heidelberg
Keyword: Transurethral Prostate Resection
Published in: World Journal of Urology / Issue 6/2021
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-020-03408-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Bladder infusion versus standard catheter removal for trial of void: a systematic review and meta-analysis

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2021

Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor

Feasibility and relevance of urine culture during stone fragmentation in patients undergoing percutaneous nephrolithotomy and retrograde intrarenal surgery: a prospective study

Enhanced recovery after surgery (ERAS) following radical cystectomy: is it worth implementing for all patients?

Robot-assisted continent urinary diversion according to the Mitrofanoff principle: results of a bicentric study

The German linguistic validation of the Wisconsin Stone Quality of Life questionnaire (WisQoL)

Bladder lesions as incidental findings during transurethral resection of the prostate: prevalence, diagnosis, and pathological findings